Cargando…
Updates on the role of adrenal steroidogenesis inhibitors in Cushing’s syndrome: a focus on novel therapies
PURPOSE: Endogenous Cushing’s syndrome (CS) is a rare disease that results from exposure to high levels of cortisol; Cushing’s disease (CD) is the most frequent form of CS. Patients with CS suffer from a variety of comorbidities that increase the risk of mortality. Surgical resection of the disease-...
Autores principales: | Fleseriu, Maria, Castinetti, Frederic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080363/ https://www.ncbi.nlm.nih.gov/pubmed/27600150 http://dx.doi.org/10.1007/s11102-016-0742-1 |
Ejemplares similares
-
Cushing’s disease: adrenal steroidogenesis inhibitors
por: Pivonello, Rosario, et al.
Publicado: (2022) -
Update on medical treatment for Cushing’s disease
por: Cuevas-Ramos, Daniel, et al.
Publicado: (2016) -
Cushing’s disease
por: Castinetti, Frederic, et al.
Publicado: (2012) -
Gallium-68 DOTA-TATE Positron Emission Tomography/Computed Tomography: Scintigraphic Changes of Adrenal Glands Following Management of Ectopic Cushing's Syndrome by Steroidogenesis Inhibitors
por: Huang, Yu-Ting, et al.
Publicado: (2014) -
Pituitary-Directed Therapies for Cushing’s Disease
por: Langlois, Fabienne, et al.
Publicado: (2018)